Nautilus Biotechnolgy
NAUT
NAUT
81 hedge funds and large institutions have $235M invested in Nautilus Biotechnolgy in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
14.95% more ownership
Funds ownership: 33.02% → 47.97% (+15%)
13% more funds holding
Funds holding: 72 → 81 (+9)
4% less capital invested
Capital invested by funds: $245M → $235M (-$10.3M)
Holders
81
Holding in Top 10
4
Calls
$2.04M
Puts
$324K
Top Buyers
| 1 | +$7.51M | |
| 2 | +$3.62M | |
| 3 | +$2.71M | |
| 4 |
CGL
Clarius Group LLC
Seattle,
Washington
|
+$2.12M |
| 5 |
PA
Perceptive Advisors
New York
|
+$1.04M |
Top Sellers
| 1 | -$4.91M | |
| 2 | -$4.61M | |
| 3 | -$3.68M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$1.93M |
| 5 |
ABG
Ally Bridge Group
New York
|
-$1.42M |